Showing results (131-140 of 582) with videos related to

Sort By:
Pageof 59
Biochemical Pharmacology|July 18, 2018
HCV-induced EGFR-ERK signaling promotes a pro-inflammatory and pro-angiogenic signature contributing to liver cancer pathogenesisMohammed Benkheil, Jan Paeshuyse, Johan Neyts, et al.
BMC Medicine|June 27, 2020
A prospect on the use of antiviral drugs to control local outbreaks of COVID-19Andrea Torneri, Pieter Libin, Joris Vanderlocht, et al.
European Journal of Medicinal Chemistry|July 31, 2016
Computer-aided identification, synthesis and evaluation of substituted thienopyrimidines as novel inhibitors of HCV replicationMarcella Bassetto, Pieter Leyssen, Johan Neyts, et al.
Antiviral Research|September 13, 2021
Comparative analysis of the molecular mechanism of resistance to vapendavir across a panel of picornavirus speciesKristina Lanko, Liang Sun, Mathy Froeyen, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2008
Synthesis and anti-CVB 3 evaluation of substituted 5-nitro-2-phenoxybenzonitrilesGerhard Pürstinger, Armando M De Palma, Günther Zimmerhofer, et al.
ACS Infectious Diseases|September 15, 2016
Bicyclic and Tricyclic "Expanded" Nucleobase Analogues of Sofosbuvir: New Scaffolds for Hepatitis C TherapiesZhe Chen, Dirk Jochmans, Therese Ku, et al.
Bioorganic & Medicinal Chemistry Letters|January 17, 2017
Shape-based virtual screening, synthesis and evaluation of novel pyrrolone derivatives as antiviral agents against HCVMarcella Bassetto, Pieter Leyssen, Johan Neyts, et al.
BMC Microbiology|December 23, 2003
Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in miceElizaveta Padalko, Erik Verbeken, Patrick Matthys, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 7, 2007
New analogs of acyclovir substituted at the side chainZofia Jahnz-Wechmann, Jerzy Boryski, Kunisuke Izawa, et al.
Pageof 59